The Daily Briefing 8.10.2021
Listen now
Description
The Marshall Project reports on an ambitious project to expand access to drug treatment in prisons and jails that has failed despite tens of millions of dollars in funding. Initiated by Congress in 2018, the program was aimed at reducing soaring overdose deaths among inmates. But so far only a small fraction—less than 2 percent of the 15,000 eligible for treatment—has received it. The article blames bureaucratic inertia and resistance to medication-assisted treatment (MAT) among correctional administrators for the disappointing rollout. While hundreds of facilities now provide such services, it’s still a small number of the nation’s 3,000 jails. At the same time, overdose deaths jumped by more than 600 percent inside prisons and by more than 200 percent inside jails in the last two decades, according to federal data. In Maine, preliminary data shows a huge reduction in overdose deaths through the MAT program: people were 60 percent less likely to die of an overdose in their first year out of prison if they had participated. Meanwhile, New Jersey’s largest needle exchange program in Atlantic City is set to close despite a surge in overdoses across the state. The city council has ordered the facility to shut down, saying that as the only place in southeast New Jersey where intravenous drug users can trade in needles, it attracts too many transient addicts. Gov. Phil Murphy is trying to block the move, and harm-reduction advocates haven’t ruled out a last-minute deal to relocate the site outside the city’s tourist district.  And finally, an editorial in the Connecticut Post argues that opioid settlement funds should be used solely for combatting opioid addiction. As nationwide opioid litigation leads to multibillion-dollar settlement agreements, many states want to ensure that the money is not siphoned off for other purposes—as was the case with tobacco settlement funds. Connecticut’s share of the $26 billion settlement with drug distributors will total about $300 million, which could disappear quickly into the state budget, the editorial points out.
More Episodes
More and more people are turning to medical cannabis products to alleviate mental health problems such as anxiety, depression, and insomnia—although there is little science indicating that the drug is safe and effective to treat these problems. Advocates of medical marijuana legalization have...
Published 10/28/21
Published 10/28/21
The New York Times finally weighs in on the risks to kids from marijuana edibles, noting that many teens underestimate the dangers associated with the drug. With pot legalization making pot more widely available, young people have come to believe marijuana is less dangerous creating a perfect...
Published 10/22/21